190.69

0.64% -1.8142

Astrazeneca Plc (AZN)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt AZN? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$192.50

Offen:

$192.64

24-Stunden-Volumen:

367.71K

Relative Volume:

0.07

Marktkapitalisierung:

$295.51B

Einnahmen:

$58.80B

Nettoeinkommen (Verlust:

$10.24B

KGV:

58.16

EPS:

3.2788

Netto-Cashflow:

$8.98B

1W Leistung:

-1.52%

1M Leistung:

-6.95%

6M Leistung:

+140.40%

1J Leistung:

+149.98%

1-Tages-Spanne:

$190.54

$193.65

1-Wochen-Bereich:

$189.35

$198.09

52-Wochen-Spanne:

$61.24

$212.71

Astrazeneca Plc Stock (AZN) Company Profile

Firmenname

Astrazeneca Plc

Sektor

Healthcare (1118)

Branche

Drug Manufacturers - General (20)

Telefon

Adresse

Mitarbeiter

96,100

Twitter

@AstraZeneca

Nächster Verdiensttermin

2026-02-10

Neueste SEC-Einreichungen

AZN's Discussions on Twitter

Compare AZN vs LLY, JNJ, ABBV, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AZN Astrazeneca Plc	190.55	298.53B	58.80B	10.24B	8.98B	3.2788
LLY Lilly Eli Co	990.79	872.68B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.78	583.29B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	222.43	398.49B	61.16B	4.19B	17.82B	2.3614
NVS Novartis Ag Adr	154.38	294.33B	54.72B	14.02B	15.32B	7.1855

Astrazeneca Plc Stock (AZN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-27	Eingeleitet	Citigroup	Buy
2025-10-27	Fortgesetzt	Jefferies	Buy
2025-10-16	Herabstufung	Deutsche Bank	Hold → Sell
2025-04-15	Eingeleitet	Exane BNP Paribas	Outperform
2025-02-13	Hochstufung	UBS	Neutral → Buy
2025-02-12	Eingeleitet	Morgan Stanley	Overweight
2024-11-20	Hochstufung	UBS	Sell → Neutral
2024-11-06	Hochstufung	Deutsche Bank	Sell → Hold
2024-09-13	Herabstufung	Deutsche Bank	Hold → Sell
2024-05-30	Eingeleitet	Goldman	Buy
2024-04-16	Hochstufung	Deutsche Bank	Sell → Hold
2024-02-08	Herabstufung	Deutsche Bank	Hold → Sell
2024-01-23	Eingeleitet	Morgan Stanley	Overweight
2024-01-16	Fortgesetzt	UBS	Sell
2024-01-03	Herabstufung	Jefferies	Buy → Hold
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-09-25	Hochstufung	Jefferies	Hold → Buy
2023-07-14	Eingeleitet	HSBC Securities	Buy
2023-07-12	Hochstufung	UBS	Neutral → Buy
2023-07-05	Herabstufung	Deutsche Bank	Buy → Hold
2023-04-11	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-01-05	Eingeleitet	BMO Capital Markets	Outperform
2022-09-15	Herabstufung	Credit Suisse	Outperform → Neutral
2022-09-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-29	Hochstufung	Argus	Hold → Buy
2022-06-14	Herabstufung	UBS	Buy → Neutral
2022-02-11	Hochstufung	DZ Bank	Sell → Hold
2021-12-07	Herabstufung	Jefferies	Buy → Hold
2021-08-12	Fortgesetzt	JP Morgan	Overweight
2021-04-12	Herabstufung	Argus	Buy → Hold
2021-03-16	Hochstufung	Jefferies	Hold → Buy
2021-02-25	Hochstufung	UBS	Neutral → Buy
2021-01-15	Eingeleitet	Deutsche Bank	Buy
2020-12-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-11-30	Hochstufung	UBS	Sell → Neutral
2020-11-11	Hochstufung	HSBC Securities	Reduce → Hold
2020-09-29	Eingeleitet	Berenberg	Buy
2019-11-22	Eingeleitet	SVB Leerink	Outperform
2019-10-25	Hochstufung	Liberum	Hold → Buy
2019-04-02	Herabstufung	UBS	Neutral → Sell
2019-02-05	Eingeleitet	Exane BNP Paribas	Outperform
2019-01-25	Hochstufung	Shore Capital	Hold → Buy
2018-12-11	Fortgesetzt	Jefferies	Hold
2018-10-09	Eingeleitet	Guggenheim	Buy
2018-08-16	Herabstufung	Jefferies	Buy → Hold
2018-03-19	Hochstufung	Jefferies	Hold → Buy
2018-02-06	Bestätigt	Leerink Partners	Mkt Perform
2018-02-05	Bestätigt	Bernstein	Outperform
2018-01-18	Bestätigt	Leerink Partners	Mkt Perform
2017-12-29	Hochstufung	JP Morgan	Neutral → Overweight
2017-10-16	Hochstufung	Credit Suisse	Neutral → Outperform
2017-09-25	Hochstufung	Exane BNP Paribas	Neutral → Outperform
2017-09-22	Hochstufung	Bernstein	Mkt Perform → Outperform

Alle ansehen

Astrazeneca Plc Aktie (AZN) Neueste Nachrichten

Mar 12, 2026

AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals - TipRanks

Mar 12, 2026

AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy - TipRanks

Mar 12, 2026

AstraZeneca (AZN) Refutes Takeover Speculation - GuruFocus

Mar 12, 2026

$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit - Caixin Global

Mar 12, 2026

Abivax denies AstraZeneca takeover rumors reported by French media - Reuters

Mar 12, 2026

Abivax Denies La Lettre Report of AstraZeneca Exclusivity - marketscreener.com

Mar 12, 2026

Abivax Denies La Lettre Report of AstraZeneca Exclusivity, Bloomberg Reports - marketscreener.com

Mar 12, 2026

Van ECK Associates Corp Sells 72,809 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga

Mar 12, 2026

SageView Advisory Group LLC Acquires New Holdings in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026

AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Sha - GuruFocus

Mar 12, 2026

BNP Paribas Financial Markets Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026

Capital Research Global Investors Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat

Mar 12, 2026

AstraZeneca in pole position to acquire Abivax - marketscreener.com

Mar 12, 2026

Morgan Stanley sees double-digit EPS growth for AstraZeneca PLC (AZN) - MSN

Mar 12, 2026

Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN) - Yahoo Finance

Mar 12, 2026

Mar 11, 2026

Franklin Resources Inc. Sells 1,585,664 Shares of AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026

Russell Investments Group Ltd. Has $66.19 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat

Mar 11, 2026